Sources confirm: A hidden genome anomaly, linked to parkinsons disease, was deliberately suppressed by three major pharmaceutical firms for over a decade. The suppressed data reveals a naturally occurring compound, cheaper than a cup of coffee, could halt neural decay. This is why they changed the diagnostic criteria in 2019.